Your browser doesn't support javascript.
loading
Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA Study.
Piccini, Jonathan P; Ahlsson, Anders; Dorian, Paul; Gillinov, Marc A; Kowey, Peter R; Mack, Michael J; Milano, Carmelo A; Perrault, Louis P; Steinberg, Jonathan S; Waldron, Nathan H; Adams, Lawrence M; Bharucha, David B; Brin, Mitchell F; Ferguson, William G; Benussi, Stefano.
Afiliación
  • Piccini JP; Duke Clinical Research Institute / Duke University Medical Center, Durham, NC. Electronic address: jonathan.piccini@duke.edu.
  • Ahlsson A; Karolinska University Hospital, Sweden.
  • Dorian P; St. Michael's Hospital, Canada.
  • Gillinov MA; Cleveland Clinic.
  • Kowey PR; Lankenau Heart Institute.
  • Mack MJ; Baylor University Medical Center.
  • Milano CA; Duke University Medical Center.
  • Perrault LP; Montreal Heart Institute, Canada.
  • Steinberg JS; University of Rochester School of Medicine & Dentistry.
  • Waldron NH; Duke Clinical Research Institute / Duke University Medical Center, Durham, NC.
  • Adams LM; AbbVie Inc.
  • Bharucha DB; AbbVie Inc.
  • Brin MF; AbbVie Inc.
  • Ferguson WG; AbbVie Inc.
  • Benussi S; University of Brescia, Italy.
Am Heart J ; 245: 51-59, 2022 03.
Article en En | MEDLINE | ID: mdl-34687654

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fibrilación Atrial / Toxinas Botulínicas Tipo A / Procedimientos Quirúrgicos Cardíacos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Am Heart J Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fibrilación Atrial / Toxinas Botulínicas Tipo A / Procedimientos Quirúrgicos Cardíacos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Am Heart J Año: 2022 Tipo del documento: Article